chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Computerised tomogram abdomen, Computerised tomogram head, Computerised tomogram pelvis, Echocardiogram
Clinical narrative: part of my left kidney was no longer receiving blood; blood clot; placed on stroke protocols.; I developed severe abdominal pain in my left side during the evening; lack of appetite; bouts of severe discomfort; This is a spontaneous report from a contactable consumer (patient). A 40-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: EW0167) via an unspecified route of administration, administered in Arm Left on 28Apr2021 12:15 (40-years-old) as 2nd dose, single for COVID-19 immunization. The patient medical history was not reported. Vaccination Facility Type was clinic. Concomitant medications included ibuprofen (ADVIL); desloratadine (CLARINEX). The patient previously took first dose of BNT162B2 (lot number=EN6208) on 07Apr2021 01:15 PM (40-years-old) on Left arm for COVID-19 immunization. It was reported that the patient developed severe abdominal pain in my left side during the evening of Wednesday, 28Apr2021 19:00. The pain appeared sporadically throughout the evening and continued through Friday, April 30. During this time, he experienced a lack of appetite and bouts of severe discomfort. Tried treating with GasX and Tylenol. Duration of Hospitalization reported as 3 days. On Saturday, 01May2021, starting around 10:30 a.m., the pain in his left-side abdominal area intensified and did not diminish. After 6 hours, he visited the ER at hospital. After being admitted to the ER, a series of blood, urine and imaging tests were performed on me. The doctor on duty reported that a CT scan showed that part of my left kidney was no longer receiving blood (disability). He was placed on Heparin and admitted to the hospital. He was diagnosed with a blood clot and placed on stroke protocols. The adverse event result in  Emergency room/department or urgent care. Treatment received for the adverse events was Heparin, fluids, blood work, urine analysis. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events abdominal pain, lack of appetite, and bouts of severe discomfort was recovering; while other events was unknown.  Events reported as serious due to hospitalization and life threatening.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Flank pain, Heparin-induced thrombocytopenia test, Hypercoagulation, Magnetic resonance imaging head, Renal infarct
Clinical narrative: part of my left kidney was no longer receiving blood; blood clot; placed on stroke protocols.; I developed severe abdominal pain in my left side during the evening; lack of appetite; bouts of severe discomfort; This is a spontaneous report from a contactable consumer (patient). A 40-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: EW0167) via an unspecified route of administration, administered in Arm Left on 28Apr2021 12:15 (40-years-old) as 2nd dose, single for COVID-19 immunization. The patient medical history was not reported. Vaccination Facility Type was clinic. Concomitant medications included ibuprofen (ADVIL); desloratadine (CLARINEX). The patient previously took first dose of BNT162B2 (lot number=EN6208) on 07Apr2021 01:15 PM (40-years-old) on Left arm for COVID-19 immunization. It was reported that the patient developed severe abdominal pain in my left side during the evening of Wednesday, 28Apr2021 19:00. The pain appeared sporadically throughout the evening and continued through Friday, April 30. During this time, he experienced a lack of appetite and bouts of severe discomfort. Tried treating with GasX and Tylenol. Duration of Hospitalization reported as 3 days. On Saturday, 01May2021, starting around 10:30 a.m., the pain in his left-side abdominal area intensified and did not diminish. After 6 hours, he visited the ER at hospital. After being admitted to the ER, a series of blood, urine and imaging tests were performed on me. The doctor on duty reported that a CT scan showed that part of my left kidney was no longer receiving blood (disability). He was placed on Heparin and admitted to the hospital. He was diagnosed with a blood clot and placed on stroke protocols. The adverse event result in  Emergency room/department or urgent care. Treatment received for the adverse events was Heparin, fluids, blood work, urine analysis. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events abdominal pain, lack of appetite, and bouts of severe discomfort was recovering; while other events was unknown.  Events reported as serious due to hospitalization and life threatening.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Ultrasound Doppler
Clinical narrative: part of my left kidney was no longer receiving blood; blood clot; placed on stroke protocols.; I developed severe abdominal pain in my left side during the evening; lack of appetite; bouts of severe discomfort; This is a spontaneous report from a contactable consumer (patient). A 40-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: EW0167) via an unspecified route of administration, administered in Arm Left on 28Apr2021 12:15 (40-years-old) as 2nd dose, single for COVID-19 immunization. The patient medical history was not reported. Vaccination Facility Type was clinic. Concomitant medications included ibuprofen (ADVIL); desloratadine (CLARINEX). The patient previously took first dose of BNT162B2 (lot number=EN6208) on 07Apr2021 01:15 PM (40-years-old) on Left arm for COVID-19 immunization. It was reported that the patient developed severe abdominal pain in my left side during the evening of Wednesday, 28Apr2021 19:00. The pain appeared sporadically throughout the evening and continued through Friday, April 30. During this time, he experienced a lack of appetite and bouts of severe discomfort. Tried treating with GasX and Tylenol. Duration of Hospitalization reported as 3 days. On Saturday, 01May2021, starting around 10:30 a.m., the pain in his left-side abdominal area intensified and did not diminish. After 6 hours, he visited the ER at hospital. After being admitted to the ER, a series of blood, urine and imaging tests were performed on me. The doctor on duty reported that a CT scan showed that part of my left kidney was no longer receiving blood (disability). He was placed on Heparin and admitted to the hospital. He was diagnosed with a blood clot and placed on stroke protocols. The adverse event result in  Emergency room/department or urgent care. Treatment received for the adverse events was Heparin, fluids, blood work, urine analysis. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events abdominal pain, lack of appetite, and bouts of severe discomfort was recovering; while other events was unknown.  Events reported as serious due to hospitalization and life threatening.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal pain lower, Computerised tomogram abdomen abnormal, Renal infarct, Urogram
Clinical narrative: part of my left kidney was no longer receiving blood; blood clot; placed on stroke protocols.; I developed severe abdominal pain in my left side during the evening; lack of appetite; bouts of severe discomfort; This is a spontaneous report from a contactable consumer (patient). A 40-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: EW0167) via an unspecified route of administration, administered in Arm Left on 28Apr2021 12:15 (40-years-old) as 2nd dose, single for COVID-19 immunization. The patient medical history was not reported. Vaccination Facility Type was clinic. Concomitant medications included ibuprofen (ADVIL); desloratadine (CLARINEX). The patient previously took first dose of BNT162B2 (lot number=EN6208) on 07Apr2021 01:15 PM (40-years-old) on Left arm for COVID-19 immunization. It was reported that the patient developed severe abdominal pain in my left side during the evening of Wednesday, 28Apr2021 19:00. The pain appeared sporadically throughout the evening and continued through Friday, April 30. During this time, he experienced a lack of appetite and bouts of severe discomfort. Tried treating with GasX and Tylenol. Duration of Hospitalization reported as 3 days. On Saturday, 01May2021, starting around 10:30 a.m., the pain in his left-side abdominal area intensified and did not diminish. After 6 hours, he visited the ER at hospital. After being admitted to the ER, a series of blood, urine and imaging tests were performed on me. The doctor on duty reported that a CT scan showed that part of my left kidney was no longer receiving blood (disability). He was placed on Heparin and admitted to the hospital. He was diagnosed with a blood clot and placed on stroke protocols. The adverse event result in  Emergency room/department or urgent care. Treatment received for the adverse events was Heparin, fluids, blood work, urine analysis. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events abdominal pain, lack of appetite, and bouts of severe discomfort was recovering; while other events was unknown.  Events reported as serious due to hospitalization and life threatening.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Decreased appetite, Dyspnoea, Failure to thrive
Clinical narrative: Breakthrough COVID requiring hospitalization. discharged home
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hyponatraemia, Hypophagia, Mental status changes, SARS-CoV-2 test positive
Clinical narrative: Breakthrough COVID requiring hospitalization. discharged home
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Breakthrough COVID requiring hospitalization. discharged home
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Myalgia, Neck pain, Sleep disorder
Clinical narrative: Pt experienced sharp stabbing/throbbing pain behind her ear/back of head that lasts ~10 seconds, then her head and neck hurt. This started happening 4/2/21, after first dose of Pfizer COVID-19 Vaccine admin 3/26/21. She took ibuprofen, aspirin and tizanidine after the initial episode. This same occurrence has happened ~5 times since initial event. She was recommended to consult her PCP and has since been referred to neurologist for follow-up.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Neck pain, Pain
Clinical narrative: Pt experienced sharp stabbing/throbbing pain behind her ear/back of head that lasts ~10 seconds, then her head and neck hurt. This started happening 4/2/21, after first dose of Pfizer COVID-19 Vaccine admin 3/26/21. She took ibuprofen, aspirin and tizanidine after the initial episode. This same occurrence has happened ~5 times since initial event. She was recommended to consult her PCP and has since been referred to neurologist for follow-up.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Acute kidney injury, Acute respiratory failure, Blood lactic acid, Blood potassium decreased
Clinical narrative: Patient vaccinated on 3/9 & 3/30. Patient developed acute necrotizing pancreatitis on 4/10 without any obvious cause (eg choledocholithiasis, alcohol, new medications, trauma, hypercalcemia, hypertriglyceridemia). Patient also had no personal or family history of pancreatitis.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Diarrhoea, Endotracheal intubation, Lipase increased, Liver function test normal
Clinical narrative: Patient vaccinated on 3/9 & 3/30. Patient developed acute necrotizing pancreatitis on 4/10 without any obvious cause (eg choledocholithiasis, alcohol, new medications, trauma, hypercalcemia, hypertriglyceridemia). Patient also had no personal or family history of pancreatitis.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging abnormal, Mental status changes, Nausea, Pancreatitis, Pancreatitis necrotising
Clinical narrative: Patient vaccinated on 3/9 & 3/30. Patient developed acute necrotizing pancreatitis on 4/10 without any obvious cause (eg choledocholithiasis, alcohol, new medications, trauma, hypercalcemia, hypertriglyceridemia). Patient also had no personal or family history of pancreatitis.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Posterior reversible encephalopathy syndrome, Respiratory failure, SARS-CoV-2 test positive, Splenic vein thrombosis, Vomiting
Clinical narrative: Patient vaccinated on 3/9 & 3/30. Patient developed acute necrotizing pancreatitis on 4/10 without any obvious cause (eg choledocholithiasis, alcohol, new medications, trauma, hypercalcemia, hypertriglyceridemia). Patient also had no personal or family history of pancreatitis.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram abnormal, Ascites, Computerised tomogram abdomen, Debridement, Lipase increased
Clinical narrative: Patient vaccinated on 3/9 & 3/30. Patient developed acute necrotizing pancreatitis on 4/10 without any obvious cause (eg choledocholithiasis, alcohol, new medications, trauma, hypercalcemia, hypertriglyceridemia). Patient also had no personal or family history of pancreatitis.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oedematous pancreatitis, Pancreatitis acute, Pancreatitis necrotising, Pleural effusion
Clinical narrative: Patient vaccinated on 3/9 & 3/30. Patient developed acute necrotizing pancreatitis on 4/10 without any obvious cause (eg choledocholithiasis, alcohol, new medications, trauma, hypercalcemia, hypertriglyceridemia). Patient also had no personal or family history of pancreatitis.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspepsia, Haematocrit decreased, Haemoglobin decreased, Nausea, Platelet count decreased
Clinical narrative: presented with altered mental status and hematemesis and admitted for metabolic encephalopathy and severe anemia secondary to upper GI bleeding.  Patient was in her usual state until 3 days prior to admission when she had her 2nd dose of COVID-19 vaccination that she started to experience generalized body aches accompanied by fever and chills a day later. She also developed epigastric pain accompanied by nausea and vomiting which was later noted to have dark colored vomitus. One day prior to admission, she went to Urgent Care and was given Famotidine. Yesterday, she was found to be obtunded with dark colored vomitus and black tarry stools and was sent to ER where she was noted to have severe anemia. GI consult called for further evaluation. Patient still confused and restless. History taken from chart and from nursing staff. Currently, no more hematemesis and no BM.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting, White blood cell count increased
Clinical narrative: presented with altered mental status and hematemesis and admitted for metabolic encephalopathy and severe anemia secondary to upper GI bleeding.  Patient was in her usual state until 3 days prior to admission when she had her 2nd dose of COVID-19 vaccination that she started to experience generalized body aches accompanied by fever and chills a day later. She also developed epigastric pain accompanied by nausea and vomiting which was later noted to have dark colored vomitus. One day prior to admission, she went to Urgent Care and was given Famotidine. Yesterday, she was found to be obtunded with dark colored vomitus and black tarry stools and was sent to ER where she was noted to have severe anemia. GI consult called for further evaluation. Patient still confused and restless. History taken from chart and from nursing staff. Currently, no more hematemesis and no BM.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Anaemia, Chills, Confusional state, Depressed level of consciousness
Clinical narrative: presented with altered mental status and hematemesis and admitted for metabolic encephalopathy and severe anemia secondary to upper GI bleeding.  Patient was in her usual state until 3 days prior to admission when she had her 2nd dose of COVID-19 vaccination that she started to experience generalized body aches accompanied by fever and chills a day later. She also developed epigastric pain accompanied by nausea and vomiting which was later noted to have dark colored vomitus. One day prior to admission, she went to Urgent Care and was given Famotidine. Yesterday, she was found to be obtunded with dark colored vomitus and black tarry stools and was sent to ER where she was noted to have severe anemia. GI consult called for further evaluation. Patient still confused and restless. History taken from chart and from nursing staff. Currently, no more hematemesis and no BM.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Discoloured vomit, Faeces discoloured, Gastrointestinal haemorrhage, Haematemesis, Melaena
Clinical narrative: presented with altered mental status and hematemesis and admitted for metabolic encephalopathy and severe anemia secondary to upper GI bleeding.  Patient was in her usual state until 3 days prior to admission when she had her 2nd dose of COVID-19 vaccination that she started to experience generalized body aches accompanied by fever and chills a day later. She also developed epigastric pain accompanied by nausea and vomiting which was later noted to have dark colored vomitus. One day prior to admission, she went to Urgent Care and was given Famotidine. Yesterday, she was found to be obtunded with dark colored vomitus and black tarry stools and was sent to ER where she was noted to have severe anemia. GI consult called for further evaluation. Patient still confused and restless. History taken from chart and from nursing staff. Currently, no more hematemesis and no BM.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mental status changes, Metabolic encephalopathy, Nausea, Pain, Pyrexia
Clinical narrative: presented with altered mental status and hematemesis and admitted for metabolic encephalopathy and severe anemia secondary to upper GI bleeding.  Patient was in her usual state until 3 days prior to admission when she had her 2nd dose of COVID-19 vaccination that she started to experience generalized body aches accompanied by fever and chills a day later. She also developed epigastric pain accompanied by nausea and vomiting which was later noted to have dark colored vomitus. One day prior to admission, she went to Urgent Care and was given Famotidine. Yesterday, she was found to be obtunded with dark colored vomitus and black tarry stools and was sent to ER where she was noted to have severe anemia. GI consult called for further evaluation. Patient still confused and restless. History taken from chart and from nursing staff. Currently, no more hematemesis and no BM.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Restlessness, Upper gastrointestinal haemorrhage, Vomiting
Clinical narrative: presented with altered mental status and hematemesis and admitted for metabolic encephalopathy and severe anemia secondary to upper GI bleeding.  Patient was in her usual state until 3 days prior to admission when she had her 2nd dose of COVID-19 vaccination that she started to experience generalized body aches accompanied by fever and chills a day later. She also developed epigastric pain accompanied by nausea and vomiting which was later noted to have dark colored vomitus. One day prior to admission, she went to Urgent Care and was given Famotidine. Yesterday, she was found to be obtunded with dark colored vomitus and black tarry stools and was sent to ER where she was noted to have severe anemia. GI consult called for further evaluation. Patient still confused and restless. History taken from chart and from nursing staff. Currently, no more hematemesis and no BM.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Dizziness, Limb discomfort, Loss of consciousness, Musculoskeletal stiffness
Clinical narrative: PT FAINTING A FEW MINUTES AFTER RECEIVING THE VACCINE
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Seizure, Tinnitus
Clinical narrative: PT FAINTING A FEW MINUTES AFTER RECEIVING THE VACCINE
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Syncope
Clinical narrative: PT FAINTING A FEW MINUTES AFTER RECEIVING THE VACCINE
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: VACCINE ADMINISTERED MORE THAN 6  HOURS AFTER VIAL PUNCTURED; INCORRECT STORAGE OF DRUG; This spontaneous report received from a pharmacist concerned a 62 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, and batch number: 042A21A expiry: 21-JUN-2021) dose was not reported, administered on 06-MAY-2021 17:15 for prophylactic vaccination. No concomitant medications were reported. On 06-MAY-2021, the subject experienced vaccine administered more than 6 hours after vial punctured. On 06-MAY-2021, the subject experienced incorrect storage of drug. The action taken with covid-19 vaccine  was not applicable. The outcome of the vaccine administered more than 6 hours after vial punctured and incorrect storage of drug was not reported. This report was non-serious.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Poor quality product administered, Product storage error
Clinical narrative: VACCINE ADMINISTERED MORE THAN 6  HOURS AFTER VIAL PUNCTURED; INCORRECT STORAGE OF DRUG; This spontaneous report received from a pharmacist concerned a 62 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, and batch number: 042A21A expiry: 21-JUN-2021) dose was not reported, administered on 06-MAY-2021 17:15 for prophylactic vaccination. No concomitant medications were reported. On 06-MAY-2021, the subject experienced vaccine administered more than 6 hours after vial punctured. On 06-MAY-2021, the subject experienced incorrect storage of drug. The action taken with covid-19 vaccine  was not applicable. The outcome of the vaccine administered more than 6 hours after vial punctured and incorrect storage of drug was not reported. This report was non-serious.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injection site vesicles
Clinical narrative: REDNESS  SWELLING PAIN HARDNESS THEN BLISTERS; ER SAID TO TAKE BENADRYL 50 MG 3 TIMES DAILY   CLIMDAMYCIN 150 MG 3 DAILY 10 DAYS. WENT BACK FOLLOW UP VA CHANGED TO 10 MG PREDNISONE 10 MG PROGRESSIVELY FOR 5 DAYS 5,4,3,2,1.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site vesicles
Clinical narrative: REDNESS  SWELLING PAIN HARDNESS THEN BLISTERS; ER SAID TO TAKE BENADRYL 50 MG 3 TIMES DAILY   CLIMDAMYCIN 150 MG 3 DAILY 10 DAYS. WENT BACK FOLLOW UP VA CHANGED TO 10 MG PREDNISONE 10 MG PROGRESSIVELY FOR 5 DAYS 5,4,3,2,1.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blister, Erythema, Pain, Swelling
Clinical narrative: REDNESS  SWELLING PAIN HARDNESS THEN BLISTERS; ER SAID TO TAKE BENADRYL 50 MG 3 TIMES DAILY   CLIMDAMYCIN 150 MG 3 DAILY 10 DAYS. WENT BACK FOLLOW UP VA CHANGED TO 10 MG PREDNISONE 10 MG PROGRESSIVELY FOR 5 DAYS 5,4,3,2,1.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Injected limb mobility decreased, Injection site pain, Injection site swelling
Clinical narrative: L arm pain causing difficulty sleeping; unable to use arm for simple tasks; pain radiating to elbow, shoulder and neck (L side)
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pain in extremity, Product administered at inappropriate site
Clinical narrative: L arm pain causing difficulty sleeping; unable to use arm for simple tasks; pain radiating to elbow, shoulder and neck (L side)
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injected limb mobility decreased, Injection site pain, Neck pain, Pain, Pain in extremity
Clinical narrative: L arm pain causing difficulty sleeping; unable to use arm for simple tasks; pain radiating to elbow, shoulder and neck (L side)
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sleep disorder
Clinical narrative: L arm pain causing difficulty sleeping; unable to use arm for simple tasks; pain radiating to elbow, shoulder and neck (L side)
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood culture negative, Cardiomyopathy, Red blood cells urine positive, Septic shock, Urine analysis abnormal
Clinical narrative: patient was admitted hypoxic and and is now unresponsive on pressors in systolic heart failure, w/o previous heart failure. She was on no medication but had a history of MS
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: White blood cells urine positive
Clinical narrative: patient was admitted hypoxic and and is now unresponsive on pressors in systolic heart failure, w/o previous heart failure. She was on no medication but had a history of MS
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Electrocardiogram, Electroconvulsive therapy, Hypoxia, Laboratory test
Clinical narrative: patient was admitted hypoxic and and is now unresponsive on pressors in systolic heart failure, w/o previous heart failure. She was on no medication but had a history of MS
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Left ventricular failure, Magnetic resonance imaging head, Unresponsive to stimuli, X-ray
Clinical narrative: patient was admitted hypoxic and and is now unresponsive on pressors in systolic heart failure, w/o previous heart failure. She was on no medication but had a history of MS
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye pain, Ocular hyperaemia
Clinical narrative: shotI think this is the right COVID
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: shotI think this is the right COVID
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Motion sickness, Nausea
Clinical narrative: Motion sickness after 15 minutes of first dose. Lasted 24 hours. Second dose on 4-21-2021-Motion sickness after 15 minutes, vertigo, nausea for three weeks. Missed work because of vertigo and motion sickness.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Motion sickness, Nausea, Vertigo
Clinical narrative: Motion sickness after 15 minutes of first dose. Lasted 24 hours. Second dose on 4-21-2021-Motion sickness after 15 minutes, vertigo, nausea for three weeks. Missed work because of vertigo and motion sickness.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19, UNK, UNK
Symptoms: Dizziness, Nausea, Syncope
Clinical narrative: After no more than 15 min. Of receiving my first dose of the moderna vaccine I started feeling severely lightheaded and nauseated. Notified the pharmacist of what I was feeling. I went back and sat down in the chair And that is the last thing I remember. I blacked out. The pharmacist said when she got to me I was slumped over in the chair. They lowered me to the floor. When I woke up I was still severely nauseated, lightheaded and I was sweating. This was not a "anxiety" issue as I have had several vaccines and never blacked out before. Let alone I have a background in the medical field and have given many shots and have drew blood on patients myself. I was feeling no anxiety at the time it was administered.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19, UNK, UNK
Symptoms: Dizziness, Hyperhidrosis, Loss of consciousness, Nausea
Clinical narrative: After no more than 15 min. Of receiving my first dose of the moderna vaccine I started feeling severely lightheaded and nauseated. Notified the pharmacist of what I was feeling. I went back and sat down in the chair And that is the last thing I remember. I blacked out. The pharmacist said when she got to me I was slumped over in the chair. They lowered me to the floor. When I woke up I was still severely nauseated, lightheaded and I was sweating. This was not a "anxiety" issue as I have had several vaccines and never blacked out before. Let alone I have a background in the medical field and have given many shots and have drew blood on patients myself. I was feeling no anxiety at the time it was administered.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Catheterisation cardiac normal, Chest pain, Electrocardiogram normal, Troponin, Ultrasound scan normal
Clinical narrative: Patient developed typical side effects of the Moderna covid vaccine, including fever, chills and headache within 1 day.  After two days in the evening,  he developed mild chest pain  The following morning (Day 3), he developed severe chest pain, nausea and vomiting and presented to the emergency department at hour facility on 5/8/21.  He was eventually diagnosed with myopericarditis with very elevated troponins and CK.  He was discharged on 5/10/21 after Troponin I level and CK started to trend down and chest pain resolved. Indomethacin treatment was ineffective.  He was then placed on a steroid, benadryl, famotidine and colchicine.   He was discharged on oral prednisone,  famotidine, colchicine, as well as a 7 day course of benadryl,
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatine phosphokinase increased, C-reactive protein increased, Catheterisation cardiac normal, Chest pain, Chills
Clinical narrative: Patient developed typical side effects of the Moderna covid vaccine, including fever, chills and headache within 1 day.  After two days in the evening,  he developed mild chest pain  The following morning (Day 3), he developed severe chest pain, nausea and vomiting and presented to the emergency department at hour facility on 5/8/21.  He was eventually diagnosed with myopericarditis with very elevated troponins and CK.  He was discharged on 5/10/21 after Troponin I level and CK started to trend down and chest pain resolved. Indomethacin treatment was ineffective.  He was then placed on a steroid, benadryl, famotidine and colchicine.   He was discharged on oral prednisone,  famotidine, colchicine, as well as a 7 day course of benadryl,
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram thorax, Echocardiogram normal, Electrocardiogram abnormal, Fibrin D dimer normal, Headache
Clinical narrative: Patient developed typical side effects of the Moderna covid vaccine, including fever, chills and headache within 1 day.  After two days in the evening,  he developed mild chest pain  The following morning (Day 3), he developed severe chest pain, nausea and vomiting and presented to the emergency department at hour facility on 5/8/21.  He was eventually diagnosed with myopericarditis with very elevated troponins and CK.  He was discharged on 5/10/21 after Troponin I level and CK started to trend down and chest pain resolved. Indomethacin treatment was ineffective.  He was then placed on a steroid, benadryl, famotidine and colchicine.   He was discharged on oral prednisone,  famotidine, colchicine, as well as a 7 day course of benadryl,
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myocarditis, Nausea, Pyrexia, Troponin I increased, Vomiting
Clinical narrative: Patient developed typical side effects of the Moderna covid vaccine, including fever, chills and headache within 1 day.  After two days in the evening,  he developed mild chest pain  The following morning (Day 3), he developed severe chest pain, nausea and vomiting and presented to the emergency department at hour facility on 5/8/21.  He was eventually diagnosed with myopericarditis with very elevated troponins and CK.  He was discharged on 5/10/21 after Troponin I level and CK started to trend down and chest pain resolved. Indomethacin treatment was ineffective.  He was then placed on a steroid, benadryl, famotidine and colchicine.   He was discharged on oral prednisone,  famotidine, colchicine, as well as a 7 day course of benadryl,
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia
Clinical narrative: This was 2nd dose. Within an hour I experienced a metal taste. It is now 1 month of  a 24 hour taste.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Dysgeusia
Clinical narrative: This was 2nd dose. Within an hour I experienced a metal taste. It is now 1 month of  a 24 hour taste.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram abnormal, Ejection fraction decreased, Electrocardiogram, Myocarditis, Troponin increased
Clinical narrative: 5/9 chills, headache and fever 5/11 Pt presented to ED with chest pressure/pain and mild shortness of breath. Pt was hospitalized for two days for Myopericarditis.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chest pain, Chills, Dyspnoea, Electrocardiogram ST segment elevation
Clinical narrative: 5/9 chills, headache and fever 5/11 Pt presented to ED with chest pressure/pain and mild shortness of breath. Pt was hospitalized for two days for Myopericarditis.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Magnetic resonance imaging heart, Myocarditis, Pyrexia, Troponin increased
Clinical narrative: 5/9 chills, headache and fever 5/11 Pt presented to ED with chest pressure/pain and mild shortness of breath. Pt was hospitalized for two days for Myopericarditis.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster, Injection site pain
Clinical narrative: SHINGLES RASH (ACHES AROUND ABDOMEN AND CHEST AND HAD WELTS/BUMPS ALL ON RIGHT SIDE FROM ARMPIT AND ALL THE WAY DOWN TO PALM AND WRIST AND RIGHT SIDE ABDOMEN, CHEST BACK AND LOWER BACK); This spontaneous report received from a patient concerned a 52 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported and batch number: 204A21A expiry: 23/JUN/2021) dose was not reported, administered on 03-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-MAY-2021, the subject experienced shingles rash (aches around abdomen and chest and had welts/bumps all on right side from armpit and all the way down to palm and wrist and right side abdomen, chest back and lower back). Treatment medications (dates unspecified) included: valaciclovir. The action taken with covid-19 vaccine  was not applicable. The patient had not recovered from shingles rash (aches around abdomen and chest and had welts/bumps all on right side from armpit and all the way down to palm and wrist and right side abdomen, chest back and lower back). This report was non-serious.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: SHINGLES RASH (ACHES AROUND ABDOMEN AND CHEST AND HAD WELTS/BUMPS ALL ON RIGHT SIDE FROM ARMPIT AND ALL THE WAY DOWN TO PALM AND WRIST AND RIGHT SIDE ABDOMEN, CHEST BACK AND LOWER BACK); This spontaneous report received from a patient concerned a 52 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported and batch number: 204A21A expiry: 23/JUN/2021) dose was not reported, administered on 03-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-MAY-2021, the subject experienced shingles rash (aches around abdomen and chest and had welts/bumps all on right side from armpit and all the way down to palm and wrist and right side abdomen, chest back and lower back). Treatment medications (dates unspecified) included: valaciclovir. The action taken with covid-19 vaccine  was not applicable. The patient had not recovered from shingles rash (aches around abdomen and chest and had welts/bumps all on right side from armpit and all the way down to palm and wrist and right side abdomen, chest back and lower back). This report was non-serious.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cardiogenic shock, Dyspnoea, Electrocardiogram ST segment elevation, Haemoptysis, Hypoxia
Clinical narrative: Youth had his second dose of Pfizer COVID vaccine on 5/6/21. On 5/7/21 he woke up reporting body ache and fatigue.  Treated with Tylenol and rest.  On 5/9/21 he was reporting that he felt short of breath, blood pressure and 02 sats were low.  He was taken to the ER for evaluation.  Determined he had pericarditis and was flown via helicopter to ER Hospital where he remains in the PICU on bipap and cardiac IV drips.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myocarditis, Nausea, Oxygen saturation decreased, Pericarditis, Respiratory failure
Clinical narrative: Youth had his second dose of Pfizer COVID vaccine on 5/6/21. On 5/7/21 he woke up reporting body ache and fatigue.  Treated with Tylenol and rest.  On 5/9/21 he was reporting that he felt short of breath, blood pressure and 02 sats were low.  He was taken to the ER for evaluation.  Determined he had pericarditis and was flown via helicopter to ER Hospital where he remains in the PICU on bipap and cardiac IV drips.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Troponin increased, Vomiting
Clinical narrative: Youth had his second dose of Pfizer COVID vaccine on 5/6/21. On 5/7/21 he woke up reporting body ache and fatigue.  Treated with Tylenol and rest.  On 5/9/21 he was reporting that he felt short of breath, blood pressure and 02 sats were low.  He was taken to the ER for evaluation.  Determined he had pericarditis and was flown via helicopter to ER Hospital where he remains in the PICU on bipap and cardiac IV drips.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bilevel positive airway pressure, Dyspnoea, Fatigue, Hypotension, Intensive care
Clinical narrative: Youth had his second dose of Pfizer COVID vaccine on 5/6/21. On 5/7/21 he woke up reporting body ache and fatigue.  Treated with Tylenol and rest.  On 5/9/21 he was reporting that he felt short of breath, blood pressure and 02 sats were low.  He was taken to the ER for evaluation.  Determined he had pericarditis and was flown via helicopter to ER Hospital where he remains in the PICU on bipap and cardiac IV drips.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Laboratory test, Oxygen saturation decreased, Pain, Pericarditis
Clinical narrative: Youth had his second dose of Pfizer COVID vaccine on 5/6/21. On 5/7/21 he woke up reporting body ache and fatigue.  Treated with Tylenol and rest.  On 5/9/21 he was reporting that he felt short of breath, blood pressure and 02 sats were low.  He was taken to the ER for evaluation.  Determined he had pericarditis and was flown via helicopter to ER Hospital where he remains in the PICU on bipap and cardiac IV drips.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Patient  received first dose covid Pfizer vaccine at different location from secondary dose.  He received second dose of Moderna in error.  No adverse event noticed.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: Patient  received first dose covid Pfizer vaccine at different location from secondary dose.  He received second dose of Moderna in error.  No adverse event noticed.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abortion spontaneous, Blood test, Dizziness, Haemorrhage, Human chorionic gonadotropin
Clinical narrative: G2 P1 Patient with LMP of 4/2/21, EDD 1/7/21  received 2nd dose of covid vaccine  and within a week experienced her first miscarriage.  patient regrets getting vaccine and is upset/frustrated with the loss and concerned about future fertility
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle spasms
Clinical narrative: G2 P1 Patient with LMP of 4/2/21, EDD 1/7/21  received 2nd dose of covid vaccine  and within a week experienced her first miscarriage.  patient regrets getting vaccine and is upset/frustrated with the loss and concerned about future fertility
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abortion spontaneous, Exposure during pregnancy, Full blood count, Human chorionic gonadotropin, Metabolic function test
Clinical narrative: G2 P1 Patient with LMP of 4/2/21, EDD 1/7/21  received 2nd dose of covid vaccine  and within a week experienced her first miscarriage.  patient regrets getting vaccine and is upset/frustrated with the loss and concerned about future fertility
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Serum ferritin
Clinical narrative: G2 P1 Patient with LMP of 4/2/21, EDD 1/7/21  received 2nd dose of covid vaccine  and within a week experienced her first miscarriage.  patient regrets getting vaccine and is upset/frustrated with the loss and concerned about future fertility
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Hyperhidrosis, Paraesthesia
Clinical narrative: Occurred within 5 mintues of receiving the vaccine. Chills, sweating, light headed, pressure in head. hard to see and hear, nausea, tingly sensation in both arms. Over in about 10 minutes.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Head discomfort, Hyperhidrosis, Hypoacusis
Clinical narrative: Occurred within 5 mintues of receiving the vaccine. Chills, sweating, light headed, pressure in head. hard to see and hear, nausea, tingly sensation in both arms. Over in about 10 minutes.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nausea, Paraesthesia, Visual impairment
Clinical narrative: Occurred within 5 mintues of receiving the vaccine. Chills, sweating, light headed, pressure in head. hard to see and hear, nausea, tingly sensation in both arms. Over in about 10 minutes.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Feeling hot, Headache, Loss of consciousness, Nausea
Clinical narrative: Patient stated that at 3am  the following day he was cold, sweating and weak.  He got up and fell on the floor twice and passed out twice.  The whole episode lasted 5 to 10 minutes.  The rest of the day he was tired, but not to the extent of the 3am episode.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Syncope
Clinical narrative: Patient stated that at 3am  the following day he was cold, sweating and weak.  He got up and fell on the floor twice and passed out twice.  The whole episode lasted 5 to 10 minutes.  The rest of the day he was tired, but not to the extent of the 3am episode.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Fall, Fatigue, Feeling cold, Hyperhidrosis
Clinical narrative: Patient stated that at 3am  the following day he was cold, sweating and weak.  He got up and fell on the floor twice and passed out twice.  The whole episode lasted 5 to 10 minutes.  The rest of the day he was tired, but not to the extent of the 3am episode.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Loss of consciousness
Clinical narrative: Patient stated that at 3am  the following day he was cold, sweating and weak.  He got up and fell on the floor twice and passed out twice.  The whole episode lasted 5 to 10 minutes.  The rest of the day he was tired, but not to the extent of the 3am episode.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Lymphadenopathy
Clinical narrative: paresthesia in fingers and toes; Fatigue; swollen lymph nodes in neck and underarm; headache; pain in arm; chills; joint pain; myalgia; low-grade fever; sore throat; This is a spontaneous report from a contactable female consumer (patient herself) of 35-years-old (non-pregnant) received first dose of BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation; solution for injection, lot number: EL9262, Expiration date: unknown) via unspecified route of administration in left arm on 26Jan2021 10:30 AM (at the age 35-years-old) as a single dose of covid-19 immunization. Patient had allergic history to environmental allergies and asthma. The patient received medications within 2 weeks of vaccination which included Cetirizine, prednisone, fluoxetine, fluticasone and did not receive other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Jan2021 at 12:00pm, patient experienced fatigue, swollen lymph nodes in neck and underarm, headache, pain in arm, chills, joint pain, myalgia, low-grade fever, sore throat, paresthesia in fingers and toes. Treatment received for the adverse events which included ibuprofen, paracetamol. Outcome of the events was recovering.  Follow-Up (15-Apr-2021): Follow-up attempts are completed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Pain in extremity, Paraesthesia, Pyrexia
Clinical narrative: paresthesia in fingers and toes; Fatigue; swollen lymph nodes in neck and underarm; headache; pain in arm; chills; joint pain; myalgia; low-grade fever; sore throat; This is a spontaneous report from a contactable female consumer (patient herself) of 35-years-old (non-pregnant) received first dose of BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation; solution for injection, lot number: EL9262, Expiration date: unknown) via unspecified route of administration in left arm on 26Jan2021 10:30 AM (at the age 35-years-old) as a single dose of covid-19 immunization. Patient had allergic history to environmental allergies and asthma. The patient received medications within 2 weeks of vaccination which included Cetirizine, prednisone, fluoxetine, fluticasone and did not receive other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Jan2021 at 12:00pm, patient experienced fatigue, swollen lymph nodes in neck and underarm, headache, pain in arm, chills, joint pain, myalgia, low-grade fever, sore throat, paresthesia in fingers and toes. Treatment received for the adverse events which included ibuprofen, paracetamol. Outcome of the events was recovering.  Follow-Up (15-Apr-2021): Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Blood cholesterol, Electrocardiogram, Headache
Clinical narrative: Strong headache; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: ER8731), intramuscular, administered in left arm on 14Apr2021 10:30 as second dose, single for COVID-19 immunization. Medical history included ongoing high blood pressure, ongoing thyroid disorder, and ongoing high cholesterol. Concomitant medication included losartan taken for high blood pressure from 2012 and ongoing; levothyroxine sodium (SYNTHROID) taken for thyroid from 2012 and ongoing; and rosuvastatin taken for high cholesterol from 19Mar2021 and ongoing. The patient previously received the first dose of BTN162B2 (Batch/lot  number:EP6955) on 19Mar2021 12:15 PM, intramuscular, administered in left arm for COVID-19 immunization, and experienced high BP 192/114. The patient experienced strong headache (medically significant) on 15Apr2021. The patient underwent lab tests and procedures which included cholesterol: 258 on 13Mar2021 (High), and electrocardiogram: normal on 10Mar2021 and 21Mar2021. Treatment for the adverse event included Panadol which gave some relief but does not go away. The outcome of the event was recovering.   Follow-up attempts are completed. No further information is expected.